NCT01297569View on ClinicalTrials.gov

"Ranibizumab Treat and Extend in Diabetic Macular Edma"

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Diabetic Macular Edema
Interventions
DRUG

Ranibizumab

Trial Locations (1)

0264

Novartis Investigative Site, Oslo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY